Characterization of lymphatic malformations using primary cells and tissue transcriptomes.

Area of Science:

• Vascular Biology
• Developmental Biology
• Genetics

Background:

• Lymphatic malformations (LMs) are congenital vascular anomalies with aberrant lymphatic vessel growth.
• While macrocystic LMs respond to sclerotherapy, effective treatments for microcystic LMs remain limited.
• Understanding the molecular basis of LMs is crucial for developing targeted therapies.

Purpose of the Study:

• To characterize lymphatic endothelial cells (LECs) from lymphatic malformations (LMs).
• To identify molecular differences between malformed and normal lymphatic endothelium.
• To explore the pathogenesis of LMs and propose new hypotheses for their development.

Main Methods:

• Isolation and primary culture of LECs from LM and normal lymphatic tissues.
• Assessment of cellular behaviors including morphology, binding, proliferation, migration, and tube formation.
• Transcriptome analysis to identify differentially expressed genes in malformed LECs.

Main Results:

• Primary cultured malformed LECs displayed distinct morphology and functional differences compared to normal LECs.
• Transcriptome analysis revealed significantly higher expression of genes such as DIRAS3 and FOXF1 in malformed LECs.
• Distinct gene expression patterns were identified in LM tissue samples, suggesting specific molecular pathogenesis.

Conclusions:

• Malformed LECs exhibit unique cellular characteristics and gene expression profiles.
• Identifying key genes like DIRAS3 and FOXF1 provides targets for understanding LM development.
• Gene expression signatures support a hypothesis linking localized LMs to disruptions in lymph node development.